Evidence map›Paper›PMID 39409061›Full record

ArticleInternational journal of molecular sciences2024

A Synbiotic Combining Chitin-Glucan and

Lena Capirchio, Christel Rousseaux, Caroline Dubuquoy, Arthur C Ouwehand, Véronique Maquet, Salvatore Modica, Edouard Louis, Pierre Desreumaux, Jan Tack

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lena CapirchioHepato-Gastroenterology Department, Centre Hospitalier Wallonie-Picarde, 7500 Tournai, Belgium.
Christel RousseauxIntestinal Biotech Development, 59045 Lille, France.ORCID 0009-0003-3618-5895
Caroline DubuquoyIntestinal Biotech Development, 59045 Lille, France.
Arthur C OuwehandHealth Sciences, IFF Health, 02460 Kantvik, Finland.ORCID 0000-0001-8348-0633
Véronique MaquetKitoZyme SA, Parc Industriel des Hauts Sarts Zone 2, Rue de Milmort 680, 4040 Herstal, Belgium.
Salvatore ModicaKitoZyme SA, Parc Industriel des Hauts Sarts Zone 2, Rue de Milmort 680, 4040 Herstal, Belgium.
Edouard LouisDepartment of Gastroenterology, Centre Hospitalier Universitaire de Liège, 4000 Liège, Belgium.
Pierre DesreumauxU1286-INFINITE-Institute for Translational Research in Inflammation, University Lille, Inserm, CHU Lille, 59000 Lille, France.
Jan TackTranslational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, 3000 Leuven, Belgium.

Funding

Service Public de Wallonie SPW-EER, convention 8588Service Public de Wallonie SPW-EER, convention 8588, Belgium
6 · The paper itself

Abstract

Chitin-glucan (CG) is a new generation of prebiotic.

Indexed as

ColonDisease Models, AnimalGlucansIrritable Bowel SyndromeLactobacillus acidophilusSynbioticsAnimalsChitinCytokinesInflammationMalePeroxidaseProbioticsRatsRats, WistarChitinCytokinesGlucansPeroxidaseabdominal painanalgesiachitin-glucaninflammationirritable bowel syndromeLactobacillus acidophilus NCFMprebioticprobioticsynbiotic

Identifiers

PMID39409061
PMCPMC11476380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.